Institut Za Onkologiju i Radiologiju Srbije

Institut Za Onkologiju i Radiologiju Srbije is an organisation in Belgrade, Serbia that has taken part in 6 EU-funded projects since 2017, receiving €1.7M in EU funding and leading 3 as coordinator.

EU funding received€1.7M
EU projects6
As coordinator3
Running now2
First EU project2017
Latest project2025
CountrySerbia
EU registration (PIC)998039791
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Za Onkologiju i Radiologiju Srbije's own share of each project, not the project's full budget.

  • Horizon Europe€1.5M · 3 projects
  • Horizon 2020€163k · 2 projects
  • 3rd Health Programme€5k · 1 project

Projects

6 EU-funded projects, newest first. Institut Za Onkologiju i Radiologiju Srbije led 3 of them as coordinator. Each links to the official record.

  • EXPAND-EVPartner

    EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healthcare

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €262ktheir share
  • RadExIORSBoostCoordinator

    Twinning to skyrocket scientific excellence towards individual radiosensitivity prediction by raising the bar in knowledge transfer, networking, and technological innovation in radiobiology

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €503ktheir share
  • STEPUPIORSCoordinator

    TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €750ktheir share
  • REPANCANCoordinator

    Drug repurposing in pancreatic ductal adenocarcinoma

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €140ktheir share
  • iPAACAssociated partner

    Innovative Partnership for Action Against Cancer

    3rd Health Programme · 2018–2021 · Project on the EU portal ↗

    €5ktheir share
  • LungCARDPartner

    Blood test for clinical therapy guidance of non-small cell lung cancer patients

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €23ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • breast cancer
  • cell biology
  • laboratory samples analysis
  • lung cancer
  • mutation
  • oncology
  • pancreatic cancer
  • pathology
  • personalized medicine
  • prostate cancer
  • radiology
  • transcriptomes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime